Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Return on Capital Employed: 2009-2025

Historic Return on Capital Employed for Gyre Therapeutics (GYRE) over the last 16 years, with Sep 2025 value amounting to 0.09%.

  • Gyre Therapeutics' Return on Capital Employed rose 79.00% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 79.00%. This contributed to the annual value of 0.16% for FY2024, which is 99.00% up from last year.
  • Gyre Therapeutics' Return on Capital Employed amounted to 0.09% in Q3 2025, which was up 14.29% from 0.08% recorded in Q2 2025.
  • Over the past 5 years, Gyre Therapeutics' Return on Capital Employed peaked at 0.68% during Q1 2023, and registered a low of -2.30% during Q1 2022.
  • In the last 3 years, Gyre Therapeutics' Return on Capital Employed had a median value of 0.08% in 2025 and averaged -0.32%.
  • Data for Gyre Therapeutics' Return on Capital Employed shows a peak YoY increase of 299bps (in 2023) and a maximum YoY decrease of 176bps (in 2023) over the last 5 years.
  • Gyre Therapeutics' Return on Capital Employed (Quarterly) stood at -1.66% in 2021, then skyrocketed by 186bps to 0.20% in 2022, then crashed by 176bps to -1.56% in 2023, then skyrocketed by 171bps to 0.15% in 2024, then skyrocketed by 79bps to 0.09% in 2025.
  • Its last three reported values are 0.09% in Q3 2025, 0.08% for Q2 2025, and 0.10% during Q1 2025.